Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Language
Publication year range
1.
Mol Divers ; 25(2): 1131-1136, 2021 May.
Article in English | MEDLINE | ID: mdl-32088812

ABSTRACT

In this paper, we reported an efficient protocol for hydration of aryl(hetero) and alkyl nitriles toward primary amides with 0.1 equiv. NaOH in NH3·H2O-DMSO under mild conditions. Various substituted nitriles are smoothly converted to the corresponding amides with good to excellent isolated yields. Gram-scale reactions were also performed to produce the desired products in high yields. In addition, the excessive hydrolysis of the nitrile to form the corresponding carboxylic acid was also achieved with increasing the amount of NaOH and prolonging the reaction time.


Subject(s)
Amides/chemistry , Ammonia/chemistry , Dimethyl Sulfoxide/chemistry , Nitriles/chemistry , Sodium Hydroxide/chemistry , Water/chemistry , Carboxylic Acids/chemistry , Catalysis , Green Chemistry Technology , Hydrolysis
2.
3.
Angew Chem Int Ed Engl ; 59(23): 8937-8940, 2020 Jun 02.
Article in English | MEDLINE | ID: mdl-32141185

ABSTRACT

Reported here is the development of a class of chiral spirosilabiindane scaffolds by Rh-catalyzed asymmetric double hydrosilation, for the first time. Enantiopure SPSiOL (spirosilabiindane diol), a new type of chiral building block for the preparation of various chiral ligands and catalysts, was readily prepared on greater than 10 gram scale using this protocol. The potential of this new spirosilabiindane scaffold in asymmetric catalysis was preliminarily demonstrated by development of the corresponding monodentate phosphoramidite ligands (SPSiPhos), which were used in both a Rh-catalyzed hydrogenation and a Pd-catalyzed intramolecular carboamination.

4.
Oxid Med Cell Longev ; 2019: 7850863, 2019.
Article in English | MEDLINE | ID: mdl-31049139

ABSTRACT

Cordyceps militaris may show good promise in protecting against chronic kidney disease (CKD) but the molecular mechanism remains unclear. CKD risk is associated with the Toll-like receptor 4/nuclear factor-kappa B (TLR4/NF-κB) signaling pathway. Cordycepin is the main component of Cordyceps militaris and may affect the TLR4/NF-κB pathway. Cordycepin was prepared by preparative HPLC. CKD patients were assigned into Cordyceps militaris (COG, 100 mg daily) and placebo (CG) groups. Cordycepin activity was measured using human embryo kidney cells (HEK293T). Biochemical indices, the levels of TLR4, NF-κB, cyclooxygenase-2 (COX2), tumor necrosis factor-alpha (TNF-α), and interleukin-1 beta (IL-1ß), were measured by real-time qRT-PCR, or ELISA kits and or Western blot. After 3-month treatment, cordycepin reduced the levels of urinal protein, blood urea nitrogen (BUN), and creatinine by 36.7%±8.6%, 12.5%±3.2%, and 18.3%±6.6%, respectively (P < 0.05). Cordyceps militaris improved lipid profile and redox capacity of CKD patients by reducing the serum levels of TG, TC, and LDL-C by 12.8%±3.6%, 15.7%±4.1%, and 16.5%±4.4% and increasing the HDL-C level by 10.1%±1.4% in the COG group when compared with the CG group, respectively (P < 0.05). The serum levels of cystatin-C (Cys-C), myeloperoxidase (MPO), and malondialdehyde (MDA) were reduced by 14.0%±3.8%, 26.9%±12.3%, and 19.7%±7.9% while nitric oxide (NO) and superoxide dismutase (SOD) were increased by 12.5%±2.9% and 25.3%±13.4% in the COG group when compared with the CG group, respectively (P < 0.05). Cordycepin reduced the levels of TLR4, NF-κB, COX2, TNF-α, and IL-1ß in HEK293T cells too (P < 0.05). However, cordycepin could not affect the levels anymore if TLR4 was silenced. Cordyceps militaris protected against CKD progression by affecting the TLR4/NF-κB lipid and redox signaling pathway via cordycepin.


Subject(s)
Deoxyadenosines/administration & dosage , NF-kappa B/metabolism , Renal Insufficiency, Chronic/drug therapy , Signal Transduction/drug effects , Toll-Like Receptor 4/metabolism , Adult , Cordyceps , Deoxyadenosines/chemistry , Female , HEK293 Cells , Humans , Interleukin-1beta/blood , Male , Middle Aged , Renal Insufficiency, Chronic/blood , Renal Insufficiency, Chronic/pathology , Tumor Necrosis Factor-alpha/blood
5.
Braz. J. Pharm. Sci. (Online) ; 55: e18173, 2019. graf
Article in English | LILACS | ID: biblio-1039035

ABSTRACT

The use of specific combinations of antigens and adjuvant represents a promising approach for increasing the immunogenicity of DNA vaccines. In the present study, we evaluated the immunity and antitumor effects of DNA vaccines with G250 as the target antigen in a mouse model of renal cell carcinoma. We constructed two recombinant plasmids, pVAX1-G250 and pVAX1-CD40L. The recombinant plasmids were injected into mice by intramuscular injection and electrical pulse stimulation. ELISA and ELISPOT experiments were performed to evaluate the corresponding humoral and cellular immune responses following immunization. To further investigate the antitumor potential of the DNA vaccines, we established a tumor-bearing mouse model expressing G250 target antigen. Our results showed that immunization with the combination of the two plasmids exerted the strongest anti-tumor effects. Therefore, our findings demonstrated the effectiveness of CD40L as an adjuvant for DNA vaccines and highlighted the promising use of these vaccines for the treatment of tumors.


Subject(s)
Animals , Female , Mice , DNA/classification , Vaccines/pharmacology , Immunity , Kidney Neoplasms , Carcinoma, Renal Cell/metabolism , CD40 Ligand/administration & dosage
6.
Pharmacol Rep ; 70(3): 607-613, 2018 Jun.
Article in English | MEDLINE | ID: mdl-29684848

ABSTRACT

BACKGROUND: Development of novel therapeutic strategies that specifically target diabetic kidney disease (DKD) is urgently needed. METHODS: Male KKAy mice were divided randomly into three equal groups - KK, KI, and KF; Male C57BL/6 mice were the control group. All KKAy mice were fed a high-fat diet. From the 16th week, the KI group was given IFN-γ, and the KF group was assigned to be treated with fludarabine. C57BL/6 mice were always fed a normal mouse diet. Every 4 weeks, body weight, random blood sugar, urine albumin and urea of all mice were measured. At the 20th week, all mice were killed, renal tissue was obtained to observe the pathological manifestations and extract proteins, and transforming growth factor- beta1 (TGF-ß1), collagen IV and Janus kinase 2/signal transducers and activators of transcription 1 (JAK2/STAT1) pathway proteins were measured by western blot. RESULTS: The present study showed that all KKAy mice appeared obese and hyperglycaemic from 12 weeks old and exhibited an increased urine albumin-to-creatinine ratio (ACR) from 16 weeks old. At the 20th week, compared to the KK group, the KI group showed lower ACR, more overexpression of P-STAT1 and less expression of TGF-ß1 and collagen IV proteins in renal tissue. The KI group mice showed less accumulation of glomerular mesangial matrix than those in the KK group. CONCLUSIONS: Our results indicate that IFN-γ might activate STAT1 to suppress the overexpression of TGF-ß1 and collagen IV proteins and attenuate the excessive accumulation of mesangial matrix under DKD conditions in KKAy mice.


Subject(s)
Diabetic Nephropathies/drug therapy , Interferon-gamma/pharmacology , Kidney/drug effects , Animals , Diabetic Nephropathies/metabolism , Disease Models, Animal , Glomerular Mesangium/metabolism , Janus Kinase 2/metabolism , Kidney/metabolism , Kidney Glomerulus/drug effects , Kidney Glomerulus/metabolism , Male , Mice , Mice, Inbred C57BL , STAT1 Transcription Factor/metabolism , Signal Transduction/drug effects , Transforming Growth Factor beta1/metabolism
7.
Biomed Pharmacother ; 70: 64-71, 2015 Mar.
Article in English | MEDLINE | ID: mdl-25776481

ABSTRACT

Clear cell renal cell carcinoma (ccRCC) is the most common form of neoplasm occurring in the adult kidney. Although significant advances have been made in treatment for ccRCC, a significant percent of patients have no benefit from currently available treatment option. MicroRNAs (miRNAs) have been reported to play central roles in regulating tumor progression, and are being explored as potentially more effective therapies and diagnostic tools for various cancers. The transcription factor E26 transformation specific-1 (ETS1) is believed to be intimately involved in tumor progression, and is frequently upregulated in tumors, including ccRCC. However, few studies have investigated the implications of ETS1 in ccRCC, and no studies have investigated the dysregulated mechanisms responsible for aberrant ETS1 expression in ccRCC. We used databases, clinical samples and target prediction algorithms to investigate aberrant miR-377 expression and potential targets in ccRCC. Our results indicate that miR-377 is downregulated in ccRCC, and that miR-377 can regulate the expression of ETS1. Further, using cell cycle analysis, MTT, luciferase and knockdown experiments, we found evidence to suggest that ETS1 is central in the development of the proliferative, metastatic and invasive phenotype of ccRCC cells. Furthermore, miR-377 was found to directly downregulate the expression of ETS1 and reduce the ability of ccRCC cells to proliferate, migrate and invade. As miR-377 was found to be differentially expressed in ccRCC, and in light of the apparent central role of ETS1 in tumor development, our results indicate that miR-377 could be useful for ccRCC diagnostics, prognostics and therapeutics.


Subject(s)
Carcinoma, Renal Cell/metabolism , MicroRNAs/metabolism , Proto-Oncogene Protein c-ets-1/metabolism , Cell Line, Tumor , Cell Movement , Cell Proliferation , Down-Regulation , Gene Expression Regulation, Neoplastic/physiology , Humans , MicroRNAs/genetics , Neoplasm Invasiveness , Proto-Oncogene Protein c-ets-1/genetics , Real-Time Polymerase Chain Reaction
8.
Biosci Biotechnol Biochem ; 78(8): 1363-70, 2014.
Article in English | MEDLINE | ID: mdl-25130738

ABSTRACT

High glucose (HG) has been reported to be associated with renal dysfunction. And one potential mechanism underlining the dysfunction is the epithelial-mesenchymal transition (EMT) of renal tubular epithelial cells. Present study showed that EMT was induced in the HG-treated renal tubular epithelial cells by promoting the expression of mesenchymal phenotype molecules, such as α-SMA and collagen I, and down-regulating the expression of epithelial phenotype molecule E-cadherin. Moreover, we have identified the down-regulation of miR-15a which was accompanied with the HG-induced EMT. And the miR-15a overexpression inhibited the α-SMA, collagen I expression, and the promotion of E-cadherin expression by targeting and down-regulating AP4 which was also significantly promoted by the HG in the renal tubular epithelial cells. Thus, this study revealed that the weakening regulation on the AP4 expression by miR-15a might contribute to the HG-induced EMT in the renal tubular epithelial cells.


Subject(s)
Down-Regulation/drug effects , Epithelial Cells/cytology , Epithelial Cells/metabolism , Epithelial-Mesenchymal Transition/drug effects , Glucose/pharmacology , Kidney Tubules/cytology , MicroRNAs/genetics , Basic Helix-Loop-Helix Leucine Zipper Transcription Factors/metabolism , Cell Line , DNA-Binding Proteins , Dose-Response Relationship, Drug , Epithelial Cells/drug effects , Humans , RNA-Binding Proteins
SELECTION OF CITATIONS
SEARCH DETAIL
...